grey
space
About Us
      Technology      Investors      News / Events      Careers      Contact
Advanced Proteome Therapeutics - Enhancing Protein Therapeutics Through Selective Modification Advanced Proteome Therapeutics - Enhancing Protein Therapeutics Through Selective Modification
space
space
NEWS
 
space

March 5, 2014
Advanced Proteome Therapeutics Reports Impressive Anticancer Activity
more...
 

January 28, 2014
Advanced Proteome Therapeutics Further Updates Ongoing Activities
more...
 

December 19, 2013
Advanced Proteome Therapeutics Provides Update on Ongoing Activities
more...
 
space

TSX-V: APC

Advancing Targeted Therapies for
                                 the War Against Cancer


Advanced Proteome has developed a patent-pending technology that combines multiple anti-cancer therapies in a single agent to directly target cancer tumors. This type of agent, carrying multiple anti-cancer therapies, has exhibited greater potency, higher specificity, and less toxicity than individual therapies that can also attack healthy cells.

Our technology is based on a proprietary protein modification platform that can be used to attach entities to therapeutic proteins to enhance their properties and/or endow them with additional functions. Advanced, targeted therapies such as ours are intended to attack primarily cancer cells and are expected to dominate the anti-cancer therapeutics market in the near future.


CEO-CFO-logo

CEO CFO Magazine Report
Advanced Proteome Therapeutics Corp is focused on developing a Protein Therapeutic that is Targeted and Combines Multiple Anti-Cancer Therapies for Greater Potency,
Higher Specificity and Less Toxicity than Individual Therapies
Read more..

Targeted Cancer Therapeutics and Immunotherapy
A 4 minute video interview with Dr. Allen Krantz and a visit to the APT Lab.



Disclaimer






space
 
Website and branding by NextPhase Strategy